Skip to content
Disclosery

Pivotal bioVenture Partners Investment Advisor LLC: OCS position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Pivotal bioVenture Partners Investment Advisor LLC on OCS, newest first. How the timeline and the estimate are built.

Pivotal bioVenture Partners Investment Advisor LLC held 1,506,250 OCS shares at 2026-06-30 per its 13F-HR filed 2026-08-13.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 1,506,250 shares
    Change vs previous 13F -174,033 shares

    6.79% of the 13F portfolio, value $20,891,688.

    13F-HR 0001012975-26-000759 filed by Pivotal bioVenture Partners Investment Advisor LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 1,680,283 shares
    Change vs previous 13F -608,375 shares

    15.97% of the 13F portfolio, value $44,678,725.

    13F-HR 0001012975-26-000421 filed by Pivotal bioVenture Partners Investment Advisor LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 2,288,658 shares
    Change vs previous 13F -12,116 shares

    17.67% of the 13F portfolio, value $45,704,500.

    13F-HR 0001012975-26-000133 filed by Pivotal bioVenture Partners Investment Advisor LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 2,300,774 shares
    Change vs previous 13F 0 shares

    23.38% of the 13F portfolio, value $40,447,607.

    13F-HR 0001012975-25-000748 filed by Pivotal bioVenture Partners Investment Advisor LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 2,300,774 shares
    Change vs previous 13F 0 shares

    27.68% of the 13F portfolio, value $44,658,023.

    13F-HR 0001012975-25-000438 filed by Pivotal bioVenture Partners Investment Advisor LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 2,300,774 shares
    Change vs previous 13F +563,078 shares

    35.43% of the 13F portfolio, value $43,783,729.

    13F-HR 0001012975-25-000233 filed by Pivotal bioVenture Partners Investment Advisor LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 1,737,696 shares
    Change vs previous 13F +141,778 shares

    19.95% of the 13F portfolio, value $29,540,832.

    13F-HR 0001012975-25-000081 filed by Pivotal bioVenture Partners Investment Advisor LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-09-30
    13F 1,595,918 shares
    Change vs previous 13F not available

    11.61% of the 13F portfolio, value $19,565,955.

    13F-HR 0001012975-24-000471 filed by Pivotal bioVenture Partners Investment Advisor LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).